These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6287560)

  • 1. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus.
    Chitrabamrung S; Rubin RL; Tan EM
    Rheumatol Int; 1981; 1(2):55-60. PubMed ID: 6287560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deoxyribonuclease-inhibitory antibodies in systemic lupus erythematosus.
    Yeh TM; Chang HC; Liang CC; Wu JJ; Liu MF
    J Biomed Sci; 2003; 10(5):544-51. PubMed ID: 12928595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus.
    Sallai K; Nagy E; Derfalvy B; Müzes G; Gergely P
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):56-9. PubMed ID: 15642985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay.
    Macanovic M; Lachmann PJ
    Clin Exp Immunol; 1997 May; 108(2):220-6. PubMed ID: 9158089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement.
    Skiljevic D; Jeremic I; Nikolic M; Andrejevic S; Sefik-Bukilica M; Stojimirovic B; Bonaci-Nikolic B
    Clin Chem Lab Med; 2013 May; 51(5):1083-91. PubMed ID: 23183758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis of keratinocytes and serum DNase I activity in patients with cutaneous lupus erythematosus: relationship with clinical and immunoserological parameters.
    Skiljevic D; Bonaci-Nikolic B; Brasanac D; Nikolic M
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):523-529. PubMed ID: 27557471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radial diffusion assay for plasma and serum deoxyribonuclease I.
    Chitrabamrung S; Bannett JS; Rubin RL; Tan EM
    Rheumatol Int; 1981; 1(2):49-53. PubMed ID: 6287559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-DNase I antibodies in systemic lupus erythematosus: diagnostic value and share in the enzyme inhibition.
    Trofimenko AS; Gontar IP; Zborovsky AB; Paramonova OV
    Rheumatol Int; 2016 Apr; 36(4):521-9. PubMed ID: 26879320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus, DNase and defective disposal of cellular debris.
    Walport MJ
    Nat Genet; 2000 Jun; 25(2):135-6. PubMed ID: 10835621
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of low serum DNase I activity and polyspecific anti-neutrophil cytoplasmic antibodies in propylthiouracil-induced lupus-like syndrome.
    Gajic-Veljic M; Bonaci-Nikolic B; Lekic B; Skiljevic D; Ciric J; Zoric S; Stojimirovic B; Nikolic M
    Rheumatology (Oxford); 2015 Nov; 54(11):2061-70. PubMed ID: 26163691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on DNase I activity and its heat-labile inhibitor in systemic lupus erythematosus].
    Kondo H
    Nihon Naika Gakkai Zasshi; 1973 Jun; 62(6):593-600. PubMed ID: 4738335
    [No Abstract]   [Full Text] [Related]  

  • 14. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.
    Martinez-Valle F; Balada E; Ordi-Ros J; Bujan-Rivas S; Sellas-Fernandez A; Vilardell-Tarres M
    Lupus; 2009 Apr; 18(5):418-23. PubMed ID: 19318394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Deoxyribonuclease Activity in Serum Samples of Patients With Systemic Lupus Erythematosus: Fluorescence-Based Method Versus ELISA.
    Vancevska A; Nikolic A; Bonaci-Nikolic B; Skiljevic D; Radojkovic D
    J Clin Lab Anal; 2016 Nov; 30(6):797-803. PubMed ID: 27086765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of antibody to denatured DNA in sera of patients with systemic lupus erythematosus and other rheumatic diseases.
    Sarai T; Miyawaki S; Kurata N; Ofuji T
    Am J Clin Pathol; 1980 Jun; 73(6):761-6. PubMed ID: 6967254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Connective tissue diseases and HEp-2 antinuclear antibodies].
    Scagliusi P; Anelli P; Fasiello V; De Lucia M; Pipitone V
    Minerva Med; 1985 May; 76(21):999-1003. PubMed ID: 3873632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study.
    Ahmed N; Shigidi M; Al Agib AN; Abdelrahman H; Taha E
    Pan Afr Med J; 2017; 27():114. PubMed ID: 28819535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of anti-entactin antibodies in patients with systemic lupus erythematosus and related disorders.
    Saxena R; Sturfelt G; Nived O; Wieslander J
    Ann Rheum Dis; 1994 Oct; 53(10):659-65. PubMed ID: 7979578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus.
    Chan TM; Leung JK; Ho SK; Yung S
    J Am Soc Nephrol; 2002 May; 13(5):1219-29. PubMed ID: 11961009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.